279 related articles for article (PubMed ID: 34724272)
1. Primary alterations during the development of hidradenitis suppurativa.
Dajnoki Z; Somogyi O; Medgyesi B; Jenei A; Szabó L; Gáspár K; Hendrik Z; Gergely P; Imre D; Póliska S; Törőcsik D; Zouboulis CC; Prens EP; Kapitány A; Szegedi A
J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):462-471. PubMed ID: 34724272
[TBL] [Abstract][Full Text] [Related]
2. Keratinocytes and immune cells in the epidermis are key drivers of inflammation in hidradenitis suppurativa providing a rationale for novel topical therapies.
Schell SL; Cong Z; Sennett ML; Gettle SL; Longenecker AL; Goldberg SR; Kirby JS; Helm MF; Nelson AM
Br J Dermatol; 2023 Feb; 188(3):407-419. PubMed ID: 36680309
[TBL] [Abstract][Full Text] [Related]
3. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.
Emelianov VU; Bechara FG; Gläser R; Langan EA; Taungjaruwinai WM; Schröder JM; Meyer KC; Paus R
Br J Dermatol; 2012 May; 166(5):1023-34. PubMed ID: 22136668
[TBL] [Abstract][Full Text] [Related]
4. Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa.
Lima AL; Karl I; Giner T; Poppe H; Schmidt M; Presser D; Goebeler M; Bauer B
Br J Dermatol; 2016 Mar; 174(3):514-21. PubMed ID: 26436522
[TBL] [Abstract][Full Text] [Related]
5. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.
Vossen ARJV; Ardon CB; van der Zee HH; Lubberts E; Prens EP
Br J Dermatol; 2019 Aug; 181(2):314-323. PubMed ID: 30657173
[TBL] [Abstract][Full Text] [Related]
6. New Data on the Features of Skin Barrier in Hidradenitis Suppurativa.
Somogyi O; Dajnoki Z; Szabó L; Gáspár K; Hendrik Z; Zouboulis CC; Dócs K; Szücs P; Dull K; Törőcsik D; Kapitány A; Szegedi A
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672635
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.
Kelly G; Hughes R; McGarry T; van den Born M; Adamzik K; Fitzgerald R; Lawlor C; Tobin AM; Sweeney CM; Kirby B
Br J Dermatol; 2015 Dec; 173(6):1431-9. PubMed ID: 26282467
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis.
Rumberger BE; Boarder EL; Owens SL; Howell MD
Inflamm Res; 2020 Oct; 69(10):967-973. PubMed ID: 32661800
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.
van der Zee HH; de Ruiter L; van den Broecke DG; Dik WA; Laman JD; Prens EP
Br J Dermatol; 2011 Jun; 164(6):1292-8. PubMed ID: 21332464
[TBL] [Abstract][Full Text] [Related]
10. Stress signalling and STAT1 activation characterize the keratinocytic gene expression pattern in Hidradenitis suppurativa.
Frings VG; Jopp L; Srivastava M; Presser D; Goebeler M; Schmidt M
J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):2488-2498. PubMed ID: 35881108
[TBL] [Abstract][Full Text] [Related]
11. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression.
Navrazhina K; Garcet S; Zheng X; Hur HB; Frew JW; Krueger JG
J Allergy Clin Immunol; 2022 Jan; 149(1):135-144.e12. PubMed ID: 34081946
[TBL] [Abstract][Full Text] [Related]
12. Single-cell transcriptomics suggest distinct upstream drivers of IL-17A/F in hidradenitis versus psoriasis.
Kim J; Lee J; Li X; Lee HS; Kim K; Chaparala V; Murphy W; Zhou W; Cao J; Lowes MA; Krueger JG
J Allergy Clin Immunol; 2023 Sep; 152(3):656-666. PubMed ID: 37271319
[TBL] [Abstract][Full Text] [Related]
13. Serum Concentration and Skin Expression of S100A7 (Psoriasin) in Patients Suffering from Hidradenitis Suppurativa.
Batycka-Baran A; Baran W; Nowicka-Suszko D; Koziol-Gałczyńska M; Bieniek A; Matusiak Ł; Łaczmański Ł; Szepietowski JC
Dermatology; 2021; 237(5):733-739. PubMed ID: 33202403
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa.
Thomi R; Yerly D; Yawalkar N; Simon D; Schlapbach C; Hunger RE
Br J Dermatol; 2017 Nov; 177(5):1358-1366. PubMed ID: 28301691
[TBL] [Abstract][Full Text] [Related]
15. Association of Hidradenitis Suppurativa With T Helper 1/T Helper 17 Phenotypes: A Semantic Map Analysis.
Thomi R; Cazzaniga S; Seyed Jafari SM; Schlapbach C; Hunger RE
JAMA Dermatol; 2018 May; 154(5):592-595. PubMed ID: 29617527
[TBL] [Abstract][Full Text] [Related]
16. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa.
Zouboulis CC; Nogueira da Costa A; Makrantonaki E; Hou XX; Almansouri D; Dudley JT; Edwards H; Readhead B; Balthasar O; Jemec GBE; Bonitsis NG; Nikolakis G; Trebing D; Zouboulis KC; Hossini AM
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):846-861. PubMed ID: 31838778
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial peptides in hidradenitis suppurativa: a systematic review.
Yao Y; Frew JW; Thomsen SF; Ring HC
Br J Dermatol; 2022 Feb; 186(2):236-244. PubMed ID: 34498267
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of the antimicrobial peptide LL-37 in hidradenitis suppurativa are associated with a Th1/Th17 immune response.
Thomi R; Schlapbach C; Yawalkar N; Simon D; Yerly D; Hunger RE
Exp Dermatol; 2018 Feb; 27(2):172-177. PubMed ID: 29222824
[TBL] [Abstract][Full Text] [Related]
19. IL-17A is a pertinent therapeutic target for moderate-to-severe hidradenitis suppurativa: Combined results from a pre-clinical and phase II proof-of-concept study.
Kimball AB; Loesche C; Prens EP; Bechara FG; Weisman J; Rozenberg I; Jarvis P; Peters T; Roth L; Wieczorek G; Kolbinger F; Jemec GBE
Exp Dermatol; 2022 Oct; 31(10):1522-1532. PubMed ID: 35638561
[TBL] [Abstract][Full Text] [Related]
20. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.
van der Zee HH; Laman JD; de Ruiter L; Dik WA; Prens EP
Br J Dermatol; 2012 Feb; 166(2):298-305. PubMed ID: 22013960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
